Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
Thi Phuong Thao HoangPhilipp SchindlerNikolaus BörnerMax MasthoffMirjam GerwingPhilippa von BeauvaisEnrico N De ToniChristian M LangeJonel TrebickaHaluk MorgülMax SeidenstickerJens RickeAndreas PascherMarkus GubaMichael IngrischMoritz WildgruberOsman ÖcalPublished in: Journal of hepatocellular carcinoma (2023)
Imaging parameters derived from baseline contrast-enhanced CT showing malignant behavior and aggressive growth patterns, along with serum AFP and history of bridging therapies, show potential as biomarkers for predicting HCC recurrence after transplantation.